Discover 1,438 paid clinical trials in Bradenton, Florida. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,438
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
for
Renal Cell Carcinoma (RCC),
Location: Tampa FL, Celebration FL, Gainesville FL, Plantation FL,
Sponsor: Exelixis
Sex: All
Age: 18+
Code: NCT05176483
Phase1, Recruiting
A Study of IDRX-42 (GSK6042981) Versus (vs) Sunitinib in Participants With Gastrointestinal Stromal Tumors After Imatinib Therapy
for
Gastrointestinal Neoplasms
Location: Tampa FL, Orlando FL, Miami FL, Jacksonville FL,
Sponsor: GlaxoSmithKline
Sex: All
Age: 18+
Code: NCT07218926
Phase3, Recruiting
A Study on the Immune Response and Safety of an Investigational Chickenpox Vaccine and a Marketed Measles, Mumps and Rubella Vaccine When Administered as Intramuscular Injection to Healthy Children 12 to 15 Months of Age
for
Chickenpox
Location: Tampa FL, Miami Lakes FL, Coral Gables FL, Richmond VA,
Sponsor: GlaxoSmithKline
Sex: All
Age: 1
Code: NCT06855160
Phase3, Recruiting
Study of Orally Administered MOMA-341 in Participants With Advanced or Metastatic Solid Tumors
for
Advanced Solid Tumor, Metastatic Solid Tumor,
Location: Tampa FL, Raleigh NC, Houston TX, St Louis MO,
Sponsor: MOMA Therapeutics
Sex: All
Age: 18+
Code: NCT06974110
Phase1, Recruiting
A Dose Escalation Phase I Study to Assess the Safety and Clinical Activity of Multiple Cancer Indications
for
Acute Myeloid Leukemia/Myelodysplastic Syndrome,
Location: Tampa FL, Buffalo NY
Sponsor: Celyad Oncology SA
Sex: All
Age: 18+
Code: NCT03018405
Phase1, Phase2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study of XB628 Alone and in Combination With Zanzalintinib in Participants With Recurrent Advanced or Metastatic Solid Tumors
Location: Tampa FL, Hickory NC, Nashville TN, Houston TX,
Sponsor: Exelixis
Sex: All
Age: 18+
Code: NCT06952010
Phase1, Recruiting
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations